Literature DB >> 24499205

New horizons for old drugs and drug leads.

Gordon M Cragg1, Paul G Grothaus, David J Newman.   

Abstract

There is mounting urgency to find new drugs for the treatment of serious infectious diseases and cancer that are rapidly developing resistance to previously effective drugs. One approach to addressing this need is through drug repurposing, which refers to the discovery of new useful activities for "old" clinically used drugs through screening them against relevant disease targets. A large number of potential drug that, for various reasons, have failed to advance to clinical and commercial use can be added to the candidates available for such purposes. The application of new techniques and methodology developed through the impressive progress made in multidisciplinary, natural product-related research in recent years should aid substantially in expediting the discovery and development process. This review briefly outlines some of these developments as applied to a number of selected natural product examples, which may also include advances in chemical synthesis of derivatives with extended biological activities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24499205     DOI: 10.1021/np5000796

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  70 in total

Review 1.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

Review 2.  Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.

Authors:  Yulin Ren; Jianhua Yu; A Douglas Kinghorn
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 3.  Current status and contemporary approaches to the discovery of antitumor agents from higher plants.

Authors:  Garima Agarwal; Peter J Blanco Carcache; Ermias Mekuria Addo; A Douglas Kinghorn
Journal:  Biotechnol Adv       Date:  2019-01-08       Impact factor: 14.227

4.  T- and B-cell immunosuppressive activity of novel α-santonin analogs with humoral and cellular immune response in Balb/c mice.

Authors:  Nisar A Dangroo; Jasvinder Singh; Nidhi Gupta; Shashank Singh; Anapurna Kaul; Mohmmed A Khuroo; Payare L Sangwan
Journal:  Medchemcomm       Date:  2016-11-11       Impact factor: 3.597

Review 5.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

Review 6.  Counting on natural products for drug design.

Authors:  Tiago Rodrigues; Daniel Reker; Petra Schneider; Gisbert Schneider
Journal:  Nat Chem       Date:  2016-04-25       Impact factor: 24.427

7.  Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway.

Authors:  Daryl Staveness; Rana Abdelnabi; Katherine E Near; Yu Nakagawa; Johan Neyts; Leen Delang; Pieter Leyssen; Paul A Wender
Journal:  J Nat Prod       Date:  2016-02-22       Impact factor: 4.050

8.  Cardiac Glycoside Constituents of Streblus asper with Potential Antineoplastic Activity.

Authors:  Yulin Ren; Wei-Lun Chen; Daniel D Lantvit; Ellen J Sass; Pratik Shriwas; Tran Ngoc Ninh; Hee-Byung Chai; Xiaoli Zhang; Djaja D Soejarto; Xiaozhuo Chen; David M Lucas; Steven M Swanson; Joanna E Burdette; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2016-12-16       Impact factor: 4.050

9.  The marine-derived pachycladin diterpenoids as novel inhibitors of wild-type and mutant EGFR.

Authors:  Mohamed M Mohyeldin; Mohamed R Akl; Abu Bakar Siddique; Hossam M Hassan; Khalid A El Sayed
Journal:  Biochem Pharmacol       Date:  2016-12-08       Impact factor: 5.858

10.  Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives.

Authors:  G Franci; G Manfroni; R Cannalire; T Felicetti; O Tabarrini; A Salvato; M L Barreca; L Altucci; V Cecchetti
Journal:  Cell Prolif       Date:  2015-12       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.